Professors Mei He and Arghya Paul are involved in a project that has been awarded a $10.8 million dollar grant for research into cancer, neurological disorders, and lung and heart disease. This is the second phase of grant funding that has been provided through The University of Kansas' Center for Molecular Analysis of Disease Pathways, a National Institutes of Health Center of Biomedical Research Excellence (COBRE). The main PI on the grant is Professor Susan Lunte, Ralph N. Adams Distinguished Professor of Chemistry and Pharmaceutical Chemistry and Director of the Adams Institute for Bioanalytical Chemistry.
CMADP's mission is "to brings together junior and senior faculty from the physical, biological, and pharmaceutical sciences at the University of Kansas and other academic institutions in Kansas to conduct multidisciplinary research to develop and implement cutting-edge technologies for elucidating the genetic, chemical, and physical mechanisms of biological processes involved in disease."
"The center’s three core facilities were established during Phase I and are focused on providing tools for junior investigators working on the development or application of new enabling technologies to study disease pathway. These facilities are also available to researchers at KU and other universities in the region: